CompletedPhase 3NCT00003596
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Studying Carcinoma of the anal canal
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radiation Therapy Oncology Group
- Principal Investigator
- Jaffer A. Ajani, MDM.D. Anderson Cancer Center
- Intervention
- cisplatin(drug)
- Enrollment
- 682 enrolled
- Eligibility
- 18-120 years · All sexes
- Timeline
- 1998 – 2016
Study locations (30)
- Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, Alabama, United States
- Mobile Infirmary Medical Center, Mobile, Alabama, United States
- Alaska Regional Hospital, Anchorage, Alaska, United States
- Providence Alaska Medical Center, Anchorage, Alaska, United States
- Foundation for Cancer Research and Education, Phoenix, Arizona, United States
- CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, Fort Smith, Arkansas, United States
- Alta Bates Comprehensive Cancer Center, Berkeley, California, United States
- Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States
- Mills-Peninsula Health Services, Burlingame, California, United States
- Mount Diablo Regional Cancer Center, Concord, California, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- California Cancer Center - Woodward Park Office, Fresno, California, United States
- Marin Cancer Institute at Marin General Hospital, Greenbrae, California, United States
- Sutter Health Western Division Cancer Research Group, Greenbrae, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI) · Eastern Cooperative Oncology Group · Cancer and Leukemia Group B · SWOG Cancer Research Network · North Central Cancer Treatment Group
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003596 on ClinicalTrials.govOther trials for Carcinoma of the anal canal
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07029152Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure ProphylaxisUniversitair Ziekenhuis Brussel
- ACTIVE NOT RECRUITINGPHASE3NCT06866574A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese MalesXiamen University
- RECRUITINGPHASE2NCT06640283Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical OutcomesInstituto do Cancer do Estado de São Paulo
- RECRUITINGNANCT06792604Host Genome Methylation: a Screening Tool in Anal Cancer DetectionAssistance Publique - Hôpitaux de Paris
- RECRUITINGPHASE3NCT06207981Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCAFederation Francophone de Cancerologie Digestive
- RECRUITINGPHASE2NCT05661188Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)Grupo Espanol Multidisciplinario del Cancer Digestivo
- RECRUITINGNCT06327568Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal SpecimensEuropean Institute of Oncology
- RECRUITINGNCT05438836Re-optimization Based Online Adaptive Radiotherapy of Anal CancerHerlev Hospital